Related Experiment Video
Updated: May 7, 2026
10:04
Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
Published on: December 2, 2022
5.5K
Hepcidin plays a negative role in liver regeneration
Liqiong Wang1, Feng Gao, Fang Yang
1Department of Pathology, Yan'an Hospital, Kunming 650051, China.
Acta Biochimica Et Biophysica Sinica
|October 15, 2013
Summary
Hepcidin (HAMP) expression, a regulator of iron metabolism, is down-regulated during liver regeneration. This down-regulation is necessary for hepatocyte proliferation and successful liver repair.
Area of Science:
- Biochemistry
- Molecular Biology
- Hepatology
Background:
- Hepcidin is a key regulator of systemic iron metabolism.
- Hepcidin expression is induced by iron overload, inflammation, and infection.
- Hepcidin regulation during liver regeneration is not well understood.
Purpose of the Study:
- To investigate the mechanism regulating hepcidin expression during liver regeneration.
- To determine the role of hepcidin in hepatic regeneration.
Main Methods:
- Investigated hepcidin expression in regenerating liver.
- Examined the effect of hepatocyte growth factor on hepcidin expression.
- Assessed hepatic regeneration in mice overexpressing hepcidin-1 after partial hepatectomy using proliferation cell nuclear antigen staining.
Main Results:
- Hepatocyte growth factor inhibited hepcidin expression during the late stage of liver regeneration.
- Mice overexpressing hepcidin-1 showed impaired hepatic regeneration.
- Hepcidin expression negatively correlates with hepatocyte proliferation.
Conclusions:
- Hepcidin plays a negative role in modulating liver regeneration.
- Down-regulation of hepcidin, leading to sustained high iron levels, is crucial for hepatocyte proliferation during liver regeneration.
Related Concept Videos
01:24Liver Regeneration
4.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.2K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
386
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
386
01:24Cirrhosis II: Pathophysiology
53
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
53
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
275
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
275
01:25Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
360
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
360